CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. 

Biotechnology

Cargo

Gina Simmons Chapman

Kari Leetch

Brian Schoelkopf

Beth Vasievich

Shishir Gadam

Shabnum Patel

Nancy Goodman

Kanika Chawla, PhD

Anup Radhakrishnan

The Research and Development team at CARGO Therapeutics is dedicated to advancing CAR T-cell therapy by innovating and optimizing processes to overcome cancer treatment resistance. This multidisciplinary team, comprising scientists and researchers specializing in analytical development, vector development, and translational medicine, collaborates to develop cutting-edge therapies and ensure their scalability and accessibility for patients in need.

Research and Development

Leadership Team

Operations and Strategy

Research and Development

About

Team members

Other teams at Cargo

Leadership Team

Operations and Strategy